(Q43274967)

English

Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome

scientific article published on 18 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome (English)

1 reference

Europe PubMed Central

18 November 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

author name string

Noriko Satoh

1

1 reference

Europe PubMed Central

18 November 2017

Akira Shimatsu

2

1 reference

Europe PubMed Central

18 November 2017

Kazuhiko Kotani

3

1 reference

Europe PubMed Central

18 November 2017

Akihiro Himeno

4

1 reference

Europe PubMed Central

18 November 2017

Takafumi Majima

5

1 reference

Europe PubMed Central

18 November 2017

Kazunori Yamada

6

1 reference

Europe PubMed Central

18 November 2017

Takayoshi Suganami

7

1 reference

Europe PubMed Central

18 November 2017

Yoshihiro Ogawa

8

1 reference

Europe PubMed Central

18 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 September 2009

1 reference

Europe PubMed Central

18 November 2017

Hypertension Research

1 reference

Europe PubMed Central

18 November 2017

32

1 reference

Europe PubMed Central

18 November 2017

11

1 reference

Europe PubMed Central

18 November 2017

1004-1008

1 reference

Europe PubMed Central

18 November 2017

https://scigraph.springernature.com/pub.10.1038/hr.2009.145

0 references

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Fish and omega-3 fatty acid intake and risk of coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI).

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Role of oxidized low density lipoprotein in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

OxLDL increases endothelial stiffness, force generation, and network formation

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Lipids and lipoproteins in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Adiponectin and Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

7 January 2021

based on heuristic

inferred from DOI database lookup

Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

7 January 2021

based on heuristic

inferred from DOI database lookup

Arterial stiffness is associated with left ventricular diastolic function in patients with cardiovascular risk factors: early detection with the use of cardio-ankle vascular index and ultrasonic strain imaging

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of oxidized LDL in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

7 January 2021

based on heuristic

inferred from DOI database lookup

A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.145

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/HR.2009.145

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43274967&oldid=1985287596"